SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-118969
Filing Date
2022-04-26
Accepted
2022-04-26 08:28:00
Documents
4
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d315632ddef14a.htm DEF 14A 288504
2 GRAPHIC g315632g30a11.jpg GRAPHIC 147705
3 GRAPHIC g315632g31b12.jpg GRAPHIC 186050
4 GRAPHIC g315632g45t78.jpg GRAPHIC 46043
  Complete submission text file 0001193125-22-118969.txt   805929
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38443 | Film No.: 22851874
SIC: 2834 Pharmaceutical Preparations